Daily average consumption of 2 long-acting opioids: an interrupted time series analysis

Oxycodone controlled release (CR) and oxymorphone extended release (ER) are frequently prescribed long-acting opioids, which are approved for twice-daily dosing. The US Food and Drug Administration approved a reformulated crush-resistant version of oxycodone CR in April 2010. To compare the daily av...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American health & drug benefits 2012-01, Vol.5 (1), p.52-60
Hauptverfasser: Puenpatom, R Amy, Szeinbach, Sheryl L, Ma, Larry, Ben-Joseph, Rami H, Summers, Kent H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!